Premium
The power of DNA double‐strand break (DSB) repair testing to predict breast cancer susceptibility
Author(s) -
Keimling Marlen,
Deniz Miriam,
Varga Dominic,
Stahl Andreea,
Schrezenmeier Hubert,
Kreienberg Rolf,
Hoffmann Isabell,
König Jochem,
Wiesmüller Lisa
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.11-200790
Subject(s) - breast cancer , dna , dna repair , medicine , cancer , genetics , biology
Most presently known breast cancer susceptibility genes have been linked to DSB repair. To identify novel markers that may serve as indicators for breast cancer risk, we performed DSB repair analyses using a case‐control design. Thus, we examined 35 women with defined familial history of breast and/or ovarian cancer (first case group), 175 patients with breast cancer (second case group), and 245 healthy women without previous cancer or family history of breast cancer (control group). We analyzed DSB repair in peripheral blood lymphocytes (PBLs) by a GFP‐based test system using 3 pathway‐specific substrates. We found increases of microhomology‐mediated nonhomologous end joining (mmNHEJ) and nonconservative single‐strand annealing (SSA) in women with familial risk vs. controls ( P =0.0001‐0.0022) and patients with breast cancer vs. controls ( P =0.0004‐0.0042). Young age (<50) at initial diagnosis of breast cancer, which could be indicative of genetic predisposition, was associated with elevated SSA using two different substrates, amounting to similar odds ratios (ORs=2.54‐4.46, P = 0.0059‐0.0095) as for familial risk (ORs=2.61‐4.05, P =0.0007‐0.0045). These findings and supporting validation data underscore the great potential of detecting distinct DSB repair activities in PBLs as method to estimate breast cancer susceptibility beyond limitations of genotyping and to predict responsiveness to therapeutics targeting DSB repair‐dysfunctional tumors.—Keimling, M., Deniz, M., Varga, D., Stahl, A., Schrezenmeier, H., Kreienberg, R., Hoffmann, I., König, J., Wiesmüller, L. The power of DNA double‐strand break (DSB) repair testing to predict breast cancer susceptibility. FASEB J. 26, 2094‐2104 (2012). www.fasebj.org